The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis.

Kelly L Bolton,Lea A Moukarzel,Ryan Ptashkin,Teng Gao,Minal Patel,Nicole Caltabellotta,Lior Z. Braunstein,Carol Aghajanian,David M. Hyman,Michael F. Berger,Luis A. Diaz,Bob T. Li,Wassim Abida,Alison M. Schram,Britta Weigelt,Claire Frances Friedman,Ahmet Zehir,Elli Papaemmanuil,Karen Anne Cadoo,Ross L. Levine

The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis.

2020

1513Background: Poly (ADP-ribose) polymerase (PARP) inhibitors are an important new class of anti-cancer therapies. Therapy-related myeloid neoplasia (tMN) has been reported following PARPi therapy...

Keywords:

Poly ADP ribose polymerase
clonal hematopoiesis
Pathology
Medicine
Cancer research
Myeloid neoplasia
Polymerase

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations